Aura Biosciences, Inc. (AURA)

NASDAQ: AURA · IEX Real-Time Price · USD
13.69
+0.18 (1.33%)
Nov 29, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Selling, General & Admin
10.094.164.52
Research & Development
25.1618.0419.62
Operating Expenses
35.2522.2124.14
Operating Income
-35.25-22.21-24.14
Interest Expense / Income
000.01
Other Expense / Income
000.06
Pretax Income
-35.25-22.21-24.2
Net Income
-35.25-22.21-24.2
Preferred Dividends
10.947.936.03
Net Income Common
-46.19-30.13-30.23
Shares Outstanding (Basic)
505
Shares Outstanding (Diluted)
505
Shares Change
1305.21%-92.08%-
EPS (Basic)
-8.95-82.06-6.52
EPS (Diluted)
-8.95-82.06-6.52
Free Cash Flow Per Share
-6.69-68.33-4.94
EBITDA
-34.42-21.38-23.69
Depreciation & Amortization
0.840.830.51
EBIT
-35.25-22.21-24.2
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).